RxDoctor Payments Data

Gregory Stephens, MD

Family Medicine · Mechanicsville, VANPI 1255306460

Payments from drug & device makers

$4,069in general payments, 2019–2025

Across 265 payments — averaging $15.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$860
  • Novo Nordisk$664
  • Amgen$546
  • AstraZeneca$295
  • Takeda Pharmaceuticals U.S.A., Inc.$193
  • Lilly USA, LLC$189
  • plus $1K from 28 others

What the payments were for

  • Food & beverage$4,050100%
  • Education$190%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,069 in reported general payments places this provider in the 85th percentile of 2,553 family medicine providers in Virginia.

See all family medicine providers in Virginia

Medicare billing

Part B allowed, 2024
$116,421
Medicare patients
350
Services billed
1,518

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide59$90,872
IngrezzaValbenazine Tosylate11$88,553
EliquisApixaban64$78,839
FarxigaDapagliflozin Propanediol73$66,816
TrulicityDulaglutide23$44,569
JardianceEmpagliflozin34$38,822
JanuviaSitagliptin Phosphate20$28,140
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog28$22,863
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog16$15,035
XareltoRivaroxaban15$13,874
Breo ElliptaFluticasone/Vilanterol16$9,817
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$8,411
Testosterone18$6,614
Lantus SolostarInsulin Glargine,hum.Rec.Anlog46$6,516
Novolog FlexpenInsulin Aspart22$4,064

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$664$90,87259 claims
PfizerEliquis$44$78,83964 claims
AstraZenecaFarxiga$295$66,81673 claims
Lilly USA, LLCTrulicity$189$44,56923 claims
Boehringer IngelheimJardiance$165$38,82234 claims
MerckJanuvia$32$28,14020 claims
GSKBreo Ellipta, Trelegy Ellipta$38$18,22829 claims
Johnson & JohnsonXarelto$81$13,87415 claims
AbbVieSynthroid$860$1,17529 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,553 family medicine providers in Virginia.

Other family medicine in Mechanicsville

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →